NASDAQ
CERo Therapeutics Holdings, Inc. (CERO) has a fcf yield of -5678.29% as of Monday, August 3, 2026. This represents a 49704.40% decrease compared to its 12-month average of -11.40%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.